1. Home
  2. SNWV vs HGLB Comparison

SNWV vs HGLB Comparison

Compare SNWV & HGLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNWV
  • HGLB
  • Stock Information
  • Founded
  • SNWV 2004
  • HGLB 1998
  • Country
  • SNWV United States
  • HGLB United States
  • Employees
  • SNWV N/A
  • HGLB N/A
  • Industry
  • SNWV
  • HGLB Trusts Except Educational Religious and Charitable
  • Sector
  • SNWV
  • HGLB Finance
  • Exchange
  • SNWV NYSE
  • HGLB Nasdaq
  • Market Cap
  • SNWV 234.2M
  • HGLB 195.7M
  • IPO Year
  • SNWV N/A
  • HGLB N/A
  • Fundamental
  • Price
  • SNWV $33.30
  • HGLB $8.92
  • Analyst Decision
  • SNWV
  • HGLB
  • Analyst Count
  • SNWV 0
  • HGLB 0
  • Target Price
  • SNWV N/A
  • HGLB N/A
  • AVG Volume (30 Days)
  • SNWV 63.4K
  • HGLB 91.8K
  • Earning Date
  • SNWV 08-11-2025
  • HGLB 01-01-0001
  • Dividend Yield
  • SNWV N/A
  • HGLB 13.16%
  • EPS Growth
  • SNWV N/A
  • HGLB N/A
  • EPS
  • SNWV N/A
  • HGLB N/A
  • Revenue
  • SNWV $36,190,000.00
  • HGLB N/A
  • Revenue This Year
  • SNWV N/A
  • HGLB N/A
  • Revenue Next Year
  • SNWV N/A
  • HGLB N/A
  • P/E Ratio
  • SNWV N/A
  • HGLB N/A
  • Revenue Growth
  • SNWV 61.50
  • HGLB N/A
  • 52 Week Low
  • SNWV $5.18
  • HGLB $6.42
  • 52 Week High
  • SNWV $39.50
  • HGLB $9.45
  • Technical
  • Relative Strength Index (RSI)
  • SNWV N/A
  • HGLB 70.77
  • Support Level
  • SNWV N/A
  • HGLB $8.70
  • Resistance Level
  • SNWV N/A
  • HGLB $9.11
  • Average True Range (ATR)
  • SNWV 0.00
  • HGLB 0.16
  • MACD
  • SNWV 0.00
  • HGLB 0.01
  • Stochastic Oscillator
  • SNWV 0.00
  • HGLB 93.42

About SNWV SANUWAVE HEALTH INC

SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing.

About HGLB Highland Global Allocation Fund

Highland Global Allocation Fund is a diversified, closed-end management investment company. The investment objective of the Fund is to seek long-term growth of capital and future income. The Fund seeks to achieve its investment objectives by investing in a portfolio of U.S. and foreign equity, debt, and money market securities. It may also invest in senior loans to domestic or foreign corporations, partnerships, and other entities that operate in a variety of industries and geographic regions.

Share on Social Networks: